Viewing Study NCT06509503



Ignite Creation Date: 2024-10-25 @ 8:00 PM
Last Modification Date: 2024-10-26 @ 3:35 PM
Study NCT ID: NCT06509503
Status: RECRUITING
Last Update Posted: None
First Post: 2024-07-13

Brief Title: Impact of Combined Oral Contraceptive Pills on Migraine
Sponsor: None
Organization: None

Study Overview

Official Title: Impact of Combined Oral Contraceptive Pills on Migraine a Randomized Controlled Trial
Status: RECRUITING
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The investigators will assess the effect of combined oral contraceptive pills COCs on migraine features and treatment response to allow better interpretation of the exact consequence of hormonal contraceptive use on migraineurs
Detailed Description: The investigators will use a questionnaire to detect the migraineur demographic and clinical features disease duration attack frequency and duration pain intensity assessed by visual analogic scale HIT score in female patients on regular COCs

Special emphasis was put on clinical phenotype for example the character of pain location associated symptoms etc vascular risk factors hypertension diabetes smoking history of cerebrovascular events and other conditions collagen disorders hepatic disorders blood diseases heart kidneys and family history
All the patients will undergo clinical neurological and general physical examinations and migraine history and associated phenotypic features will be established

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None